📰 Alkermes News
Page 45 - Alkermes News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alkermes. Real-time updates on events, politics, business and more.
February 9, 2023
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. GMT) on Thursday, Feb. 16, 2023 to...
February 2, 2023
WALTHAM, Mass., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Danforth Advisors, LLC, today announced the promotion of Wendy Nelson, PhD, to the newly created role...
February 2, 2023
Danforth Advisors, LLC, today announced the promotion of Wendy Nelson, PhD, to the newly created role of Chief Business Officer – guiding the firm’s corporate
January 25, 2023
The Depressive Disorder report is an in-depth examination of the global Depressive Disorder’s general consumption structure, developme
January 19, 2023
Ketamine poisonings in the US increased 81% between 2019 and 2021, according to a new analysis of calls to poison control centers.
January 18, 2023
TandemAI Announces Appointment of Alessandro Monge, Ph.D., as Chief Business Officer - read this article along with other careers information, tips and advice on BioSpace
January 11, 2023
Patients with major depressive disorder who have sleep disturbances are at increased risk for developing other psychiatric disorders later on, new research suggests.
January 9, 2023
Bank of America increased their target price on shares of Alkermes from $27.00 to $28.00 in a report on Sunday.
January 9, 2023
/PRNewswire/ -- A team led by researchers at NYU Langone Healths Perlmutter Cancer Center has identified a gene that drives development of the second most...
January 9, 2023
A team led by researchers at NYU Langone Health's Perlmutter Cancer Center has identified a gene that drives development of the second most common type of lung carcinoma, offering greater insight into how the disease might someday be treated.